Kelly S.E. Tanaka

Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus

Sung Joon Kim, Lynette Cegelski, Dirk Stueber et al. · Journal of Molecular Biology · 2008 · 130 citations · Full text

Biosynthesis, Engineering, Antimicrobial Susceptibility +9

Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium

Gary J. Patti, Sung Joon Kim, Tsyr‐Yan Yu et al. · Journal of Molecular Biology · 2009 · 79 citations · Full text

Antimicrobial Resistance Gene, Antimicrobial Susceptibility, Health Sciences +11

Linking Bisphosphonates to the Free Amino Groups in Fluoroquinolones: Preparation of Osteotropic Prodrugs for the Prevention of Osteomyelitis

Tom J. Houghton, Kelly S.E. Tanaka, Ting Kang et al. · Journal of Medicinal Chemistry · 2008 · 74 citations

Pharmaceutical Science, Sclerostin, Bioorganic Chemistry +19

Glucosidase-Catalyzed Hydrolysis of α-<scp>d</scp>-Glucopyranosyl Pyridinium Salts:  Kinetic Evidence for Nucleophilic Involvement at the Glucosidation Transition State

Xicai Huang, Kelly S.E. Tanaka, Andrew J. Bennet · Journal of the American Chemical Society · 1997 · 55 citations

Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis

Kelly S.E. Tanaka, Tom J. Houghton, Ting Kang et al. · Bioorganic & Medicinal Chemistry · 2008 · 44 citations

Medicinal Chemistry, Anti-inflammatory, Osteopathy +8